Ticagrelor
Ticagrelor is an antiplatelet drug used to reduce clot-related events in people with acute coronary syndromes or certain vascular disease risks. It reversibly blocks the P2Y12 ADP receptor on platelets, reducing platelet activation and aggregation and thereby lowering the chance of arterial thrombosis.
Interactions
Supplement interactions on fileNo supplement in this library is recorded as interacting with this medication. Coverage is partial — 171 of 216 medications have interaction data, drawn from the 107 supplements written up so far. Absence here is incomplete coverage, not a safety claim.
- Trade names
- Ticagrelor (Brilinta)
- family
- antiplatelet agents